Blog

Autoimmune Disease Predispositions and Pregnancy

Autoimmune Disease Predispositions and Pregnancy

Many autoimmune diseases can raise a patient’s chances for adverse pregnancy outcomes, which is why expectant mothers with antiphospholipid syndrome, lupus, rheumatoid arthritis, and other autoimmune disorders are considered high-risk pregnancies. However, many people remain undiagnosed for autoimmune conditions.

Autoimmune diseases are thought to arise from a combination of a person’s genetics and environment. Although being genetically predisposed to autoimmunity might raise a person’s chances for developing an autoimmune disease, it is not a guarantee.

Physiology

Human Leukocyte Antigen (HLA) genes play an integral role in activating the immune response. Some HLA alleles change the features of a person’s HLAs to make them more likely to inappropriately trigger the immune response and develop an autoimmune condition. An autoimmune disease predisposition test looks at different alleles of the patient’s HLA genes which might predispose the patient to autoimmune issues than can interfere with a healthy pregnancy.

Our analysis indicates HLA alleles and haplotypes that have been shown to predispose to certain autoimmune conditions. The presence of one or more predisposing HLA alleles/haplotypes is not diagnostic of the existence of an autoimmune condition. However, when combined with other analysis in the IRMA report, the presence of specific alleles/haplotypes can provide valuable insight into the state of the patient’s immune system that could be contributing to failure to initiate or maintain pregnancy. HLA alleles and haplotypes that contribute to autoimmunity may also directly lead to an inability to appropriately establish maternal immune tolerance to an embryo or fetus.

Back to blog
We love questions

Talk to an expert

Pregmune’s fertility services experts are available to help you get started and to answer any questions you may have along the way.

Medical Disclaimer

Patients and physicians should always consult with a licensed medical professional before making any clinical decisions, including starting or discontinuing any treatment. Any information provided by Pregmune, including but not limited to the IRMA Report, AIMY Report, test results, risk estimates, supporting documentation, email communications or other related content (collectively, "Pregmune Content"), is intended for informational purposes only. This content is not medical advice and should not be used as a substitute for professional medical evaluation, diagnosis, or treatment. Pregmune Content is not a recommendation for any specific treatment plan, therapy, medication, or course of action. It is designed to support, not replace, the relationship between patients and their qualified healthcare providers. Pregmune does not provide medical care, and its reports and communications should never delay or override clinical judgment.